Edwards Lifesciences Corp.
(NYSE : EW)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.38%535.681.0%$621.33m
DHRDanaher Corp. 0.55%298.680.7%$606.74m
ABTAbbott Laboratories 0.52%121.550.8%$563.61m
ISRGIntuitive Surgical, Inc. 0.45%997.002.3%$467.88m
MDTMedtronic Plc -0.27%130.900.6%$453.00m
ALGNAlign Technology, Inc. -0.93%693.496.3%$434.57m
DXCMDexCom, Inc. 1.66%519.857.8%$346.49m
NURONeuroMetrix, Inc. 11.05%14.577.7%$344.42m
SYKStryker Corp. -0.88%267.711.3%$318.77m
BSXBoston Scientific Corp. -0.72%45.551.0%$296.01m
EWEdwards Lifesciences Corp. 1.00%114.410.4%$285.16m
AAgilent Technologies, Inc. 0.33%153.571.6%$283.14m
IDXXIDEXX Laboratories, Inc. 1.45%688.573.8%$256.16m
BDXBecton, Dickinson & Co. 0.05%256.251.0%$254.29m
AHPIAllied Healthcare Products, Inc. 15.65%10.270.7%$228.87m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.